TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $396,496 | -1.5% | 25,630 | 0.0% | 0.04% | +18.8% |
| Q2 2023 | $402,647 | -4.7% | 25,630 | 0.0% | 0.03% | -15.8% |
| Q1 2023 | $422,382 | +5.6% | 25,630 | 0.0% | 0.04% | +2.7% |
| Q4 2022 | $399,828 | +20.4% | 25,630 | 0.0% | 0.04% | +8.8% |
| Q3 2022 | $332,000 | -7.8% | 25,630 | 0.0% | 0.03% | -19.0% |
| Q2 2022 | $360,000 | -1.9% | 25,630 | 0.0% | 0.04% | +31.2% |
| Q1 2022 | $367,000 | +5.2% | 25,630 | 0.0% | 0.03% | +28.0% |
| Q4 2021 | $349,000 | -16.9% | 25,630 | 0.0% | 0.02% | -10.7% |
| Q3 2021 | $420,000 | -2.6% | 25,630 | 0.0% | 0.03% | +7.7% |
| Q2 2021 | $431,000 | -91.2% | 25,630 | -90.9% | 0.03% | -96.5% |
| Q3 2019 | $4,871,000 | -33.6% | 283,200 | -31.7% | 0.74% | -27.8% |
| Q2 2019 | $7,338,000 | -12.8% | 414,627 | +0.4% | 1.02% | -6.9% |
| Q1 2019 | $8,416,000 | – | 413,136 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |